| Kakanerveux vs Jin | 10–13 | 43.48% |
| Kakanerveux vs Kazuya | 7–13 | 35.00% |
| Kakanerveux vs Hwoarang | 8–10 | 44.44% |
| Kakanerveux vs King | 3–13 | 18.75% |
| Kakanerveux vs Steve | 6–9 | 40.00% |
| Kakanerveux vs Reina | 11–4 | 73.33% |
| Kakanerveux vs Law | 1–10 | 9.09% |
| Kakanerveux vs Lili | 3–6 | 33.33% |
| Kakanerveux vs Lars | 3–6 | 33.33% |
| Kakanerveux vs Heihachi | 4–5 | 44.44% |
| Kakanerveux vs Alisa | 5–3 | 62.50% |
| Kakanerveux vs Victor | 2–6 | 25.00% |
| Kakanerveux vs Fahkumram | 2–6 | 25.00% |
| Kakanerveux vs Yoshimitsu | 3–3 | 50.00% |
| Kakanerveux vs Xiaoyu | 4–2 | 66.67% |
| Kakanerveux vs Bryan | 1–5 | 16.67% |
| Kakanerveux vs Nina | 4–2 | 66.67% |
| Kakanerveux vs Devil Jin | 1–4 | 20.00% |
| Kakanerveux vs Asuka | 0–4 | 0.00% |
| Kakanerveux vs Dragunov | 0–4 | 0.00% |
| Kakanerveux vs Anna | 0–4 | 0.00% |
| Kakanerveux vs Claudio | 2–1 | 66.67% |
| Kakanerveux vs Leroy | 2–1 | 66.67% |
| Kakanerveux vs Jun | 1–2 | 33.33% |
| Kakanerveux vs Azucena | 0–3 | 0.00% |
| Kakanerveux vs Paul | 0–2 | 0.00% |
| Kakanerveux vs Jack-8 | 0–2 | 0.00% |
| Kakanerveux vs Shaheen | 1–1 | 50.00% |
| Kakanerveux vs Lee | 0–2 | 0.00% |
| Kakanerveux vs Kuma | 0–2 | 0.00% |
| Kakanerveux vs Eddy | 0–2 | 0.00% |
| Kakanerveux vs Panda | 0–1 | 0.00% |
| Kakanerveux vs Zafina | 0–1 | 0.00% |
| Kakanerveux vs Clive | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.